Established in 2008 and headquartered in Montgomery, Alabama, Kowa Pharmaceuticals America, Inc., is committed to developing and delivering safe, effective solutions in the field of cardiometabolic therapeutics. We do this by maintaining high ethical and professional standards—and it all starts with people. By empowering our employees to live this mission, we can create a healthier vision for the future. At Kowa Pharmaceuticals America, Inc., we pride ourselves on having created a unique corporate culture with a work environment that is achievement focused and where employees can build successful careers. Our diverse workforce includes talented people who are strong team players looking for growth and challenge. To apply for an open position, please visit: https://www.kowapharma.com/careers/ Thank you for considering Kowa Pharmaceuticals America, Inc. in your employment search. For more information about Kowa Pharmaceuticals America, Inc., please visit our corporate website at www.kowapharma.com.
Kowa Pharmaceuticals America, Inc.的外部链接
530 Industrial Park Blvd
US，Alabama， Montgomery，36117
Kowa Pharmaceuticals America, Inc.转发了
At Kowa Pharmaceuticals America, Inc., we are proud to have a long history of successfully co-promoting products within primary care, and this new partnership with Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) aligns closely with our focus and expertise in the primary care setting. Learn more here: https://lnkd.in/e6TZHjfw #ImmunoDermatology #ClinicalDermatology #atopicdermatitis #seborrheicdermatitis #plaquepsoriasis #healthcare
At Kowa Pharmaceuticals America, Inc., we are proud to have a long history of successfully co-promoting products within primary care, and this new partnership with Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) aligns closely with our focus and expertise in the primary care setting. Learn more here: https://lnkd.in/e6TZHjfw #ImmunoDermatology #ClinicalDermatology #atopicdermatitis #seborrheicdermatitis #plaquepsoriasis #healthcare
Today, we are excited to announce a U.S. co-promote agreement with Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) to significantly extend the reach to primary care practitioners and pediatricians who treat millions of individuals each year suffering from atopic dermatitis, seborrheic dermatitis, and plaque psoriasis. Learn more here: https://lnkd.in/e6TZHjfw #ImmunoDermatology #ClinicalDermatology #atopicdermatitis #seborrheicdermatitis #plaquepsoriasis #healthcare